In the current study, we provided evidence that SphK1/S1P/S1PR1/3 signaling played an important role in ovarian cancer angiogenesis and blockage of this pathway could significantly inhibit the angiogenic process of the cancer. This evidence concerns the gene SPHK1 and ovarian cancer.